Article Information
History
- August 4, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Yves Gillet, M.D., Ph.D.1,2,+,
- Anne Tristan, Pharm.D., Ph.D.2,
- Jean-Philippe Rasigade, M.D., Ph.D.2,
- Mitra Saadatian-Elahi, Ph.D.3,
- Coralie Bouchiat, Pharm.D., Ph.D.2,
- Michele Bes, Ph.D.2,
- Oana Dumitrescu, M.D., Ph.D.2,
- Marie Leloire, M.D.,
- Céline Dupieux, Pharm.D., Ph.D.2,
- Frédéric Laurent, Pharm.D., Ph.D.2,
- Gérard Lina, M.D., Ph.D.2,
- Jerome Etienne, M.D., Ph.D.2,
- Philippe Vanhems, M.D., Ph.D.3,
- Laurent Argaud, M.D., Ph.D.4,
- Francois Vandenesch, M.D., Ph.D.2,*,
- the PVL pneumonia study group†
- 1Pediatric Emergency & Intensive Care Unit, Hospices Civils de Lyon, Lyon, France
- 2French Reference Center for Staphylococci, Hospices Civils de Lyon, Lyon, France
- 3Infection Control and Epidemiology Department, Hospices Civils de Lyon, Lyon, France
- 4Medical Intensive Care Unit, Hospices Civils de Lyon, Lyon, France